IL-4 Attenuates Pulmonary Epithelial Cell-Mediated Suppression of T Cell Priming.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractWe have previously shown that Th2-polarized airway inflammation facilitates sensitization towards new, protein antigens. In this context, we could demonstrate that IL-4 needs to act on cells of the hematopoetic and the structural compartment in order to facilitate sensitization towards new antigens. We thus aimed to elucidate possible mechanisms of action of IL-4 on structural cells choosing to analyze pulmonary epithelial cells as an important part of the lung's structural system. We used a co-culture system of DC- or APC-dependent in vitro priming of T cells, co-cultivated on a layer of cells of a murine pulmonary epithelial cell line (LA-4) pretreated with or without IL-4. Effects on T cell priming were analyzed via CFSE-dilution and flow cytometric assessment of activation status. Pulmonary epithelial cells suppressed T cell proliferation in vitro but this effect was attenuated by pre-treatment of the epithelial cells with IL-4. Transwell experiments suggest that epithelial-mediated suppression of T cell activation is mostly cell-contact dependent and leads to attenuation in an early naive T cell phenotype. Secretion of soluble factors like TARC, TSLP, GM-CSF and CCL20 by epithelial cells did not change after IL-4 treatment. However, analysis of co-stimulatory expression on pulmonary epithelial cells revealed that pre-treatment of epithelial cells with IL-4 changed expression GITR-L, suggesting a possible mechanism for the effects observed. Our studies provide new insight into the role of IL-4 during the early phases of pulmonary sensitization: The inhibitory activity of pulmonary epithelial cells in homeostasis is reversed in the presence of IL-4, which is secreted in the context of Th2-dominated allergic airway inflammation. This mechanism might serve to explain facilitated sensitization in the clinical context of polysensitization where due to a pre-existing sensitization increased levels of IL-4 in the airways might facilitate T cell priming towards new antigens.
CitationIL-4 Attenuates Pulmonary Epithelial Cell-Mediated Suppression of T Cell Priming. 2012, 7 (9):e45916 PLoS ONE
AffiliationPediatric Pneumology, Allergology and Neonatology, Medical School Hannover, Hannover, Germany.
The following license files are associated with this item:
- STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease.
- Authors: Chapoval SP, Dasgupta P, Smith EP, DeTolla LJ, Lipsky MM, Kelly-Welch AE, Keegan AD
- Issue date: 2011 Feb 15
- IL-23 secreted by bronchial epithelial cells contributes to allergic sensitization in asthma model: role of IL-23 secreted by bronchial epithelial cells.
- Authors: Lee HS, Park DE, Lee JW, Chang Y, Kim HY, Song WJ, Kang HR, Park HW, Chang YS, Cho SH
- Issue date: 2017 Jan 1
- STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells.
- Authors: Pillemer BB, Qi Z, Melgert B, Oriss TB, Ray P, Ray A
- Issue date: 2009 Jul 1
- Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells.
- Authors: Torres D, Dieudonné A, Ryffel B, Vilain E, Si-Tahar M, Pichavant M, Lassalle P, Trottein F, Gosset P
- Issue date: 2010 Jul 1
- Direct contact between dendritic cells and bronchial epithelial cells inhibits T cell recall responses towards mite and pollen allergen extracts in vitro.
- Authors: Papazian D, Wagtmann VR, Hansen S, Würtzen PA
- Issue date: 2015 Aug